Antiretroviral therapies significantly improved morbidity and mortality of HIV-infected people. However, regimens are complex to be taken and in the last years adherence to drugs has been raised as a crucial factor for therapeutical efficacy. The narrative medicine is a developing approach to complement information obtained by traditional measures on health status. Our objective has been to investigate through the narrative-based medicine approach patterns of non-adherence and reasons for suboptimal adherence. This information may help to design intervention strategies aimed to improve adherence to antiretroviral drugs.
Adherence to antiretroviral therapies in people with HIV infection: a qualitative approach from a narrative-based medicine study / A., Tomasini; R., Murri; Guaraldi, Giovanni; N., Squillace; G., Orlando; S., Zona; I., Mazeu; M. S., Aloisi; M., Bossola. - ELETTRONICO. - not applicable:(2008), pp. P177-P177. ((Intervento presentato al convegno Ninth International Congress on Drug Therapy in HIV Infection tenutosi a Glasgow, UK nel 09-13 November 2008.
Adherence to antiretroviral therapies in people with HIV infection: a qualitative approach from a narrative-based medicine study
GUARALDI, Giovanni;
2008
Abstract
Antiretroviral therapies significantly improved morbidity and mortality of HIV-infected people. However, regimens are complex to be taken and in the last years adherence to drugs has been raised as a crucial factor for therapeutical efficacy. The narrative medicine is a developing approach to complement information obtained by traditional measures on health status. Our objective has been to investigate through the narrative-based medicine approach patterns of non-adherence and reasons for suboptimal adherence. This information may help to design intervention strategies aimed to improve adherence to antiretroviral drugs.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
